Neuroscience - Schizophrenia - Breast Cancer - Renal Cell Carcinoma - Kidney Injury Studies
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B1480 Chlorpromazine HCl中文名: 盐酸氯丙嗪Summary: 多巴胺拮抗剂
- B1483 Fenoldopam中文名: 非诺多泮Target: D1 and D5 ReceptorsSummary: D1样多巴胺受体部分激动剂
- B1564 Ranitidine中文名: 盐酸雷尼替丁Target: Histamine H2 ReceptorsSummary: 组胺H2受体拮抗剂
- B1485 Pergolide mesylate中文名: 甲磺酸培高利特Target: D1 and D5 Receptors|D2 ReceptorsSummary: 多巴胺能激动剂
- B2236 Desvenlafaxine中文名: 去甲文拉法辛Target: 5-HT Transporters|Norepinephrine transportersSummary: 5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂
- B1477 Lurasidone HCl中文名: 盐酸鲁拉西酮Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
- B1490 Quetiapine Fumarate1 Citation中文名: 富马酸奎硫平Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 ReceptorsSummary: 多巴胺受体拮抗剂
- B1001 Loxapine1 Citation中文名: 洛沙平Target: 5-HT2 ReceptorsSummary: 5-HT受体拮抗剂
- B2232 Aripiprazole中文名: 阿立哌唑Target: 5-HT1 ReceptorsSummary: 5-HT受体部分激动剂
- B2240 Olanzapine中文名: 奥氮平Target: 5-HT2 Receptors|D2 ReceptorsSummary: 5-HT2A和多巴胺D2受体的拮抗剂